DK0815105T3 - Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister - Google Patents
Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonisterInfo
- Publication number
- DK0815105T3 DK0815105T3 DK96905333T DK96905333T DK0815105T3 DK 0815105 T3 DK0815105 T3 DK 0815105T3 DK 96905333 T DK96905333 T DK 96905333T DK 96905333 T DK96905333 T DK 96905333T DK 0815105 T3 DK0815105 T3 DK 0815105T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor antagonists
- piperazine derivatives
- substituted piperazine
- heterocyclic substituted
- tachykinin receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40478895A | 1995-03-15 | 1995-03-15 | |
| PCT/US1996/001437 WO1996028441A1 (en) | 1995-03-15 | 1996-02-06 | Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0815105T3 true DK0815105T3 (da) | 2002-01-21 |
Family
ID=23601038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96905333T DK0815105T3 (da) | 1995-03-15 | 1996-02-06 | Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5840726A (no) |
| EP (1) | EP0815105B1 (no) |
| JP (1) | JP3825472B2 (no) |
| KR (1) | KR19980703032A (no) |
| CN (1) | CN1067068C (no) |
| AR (1) | AR002715A1 (no) |
| AT (1) | ATE206421T1 (no) |
| AU (1) | AU697599B2 (no) |
| CA (1) | CA2215333C (no) |
| DE (1) | DE69615670T2 (no) |
| DK (1) | DK0815105T3 (no) |
| ES (1) | ES2164235T3 (no) |
| FI (1) | FI973671A0 (no) |
| HU (1) | HUP9702149A3 (no) |
| IL (1) | IL117453A (no) |
| NO (1) | NO314693B1 (no) |
| NZ (1) | NZ302948A (no) |
| PT (1) | PT815105E (no) |
| TW (1) | TW464647B (no) |
| WO (1) | WO1996028441A1 (no) |
| ZA (1) | ZA961954B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2175161T3 (es) * | 1995-12-18 | 2002-11-16 | Fujisawa Pharmaceutical Co | Derivados de piperazina como antagonistas de taquiquinina. |
| DE19939910A1 (de) * | 1999-08-23 | 2001-03-01 | Morphochem Ag | Neue Verbindungen, die Tryptase-Aktivität hemmen |
| US20040033986A1 (en) * | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
| US7652039B2 (en) * | 2002-05-17 | 2010-01-26 | Sequella, Inc. | Methods of use and compositions for the diagnosis and treatment of infectious disease |
| US7456222B2 (en) * | 2002-05-17 | 2008-11-25 | Sequella, Inc. | Anti tubercular drug: compositions and methods |
| EP1670314A4 (en) * | 2003-09-05 | 2009-02-25 | Sequella Inc | METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS |
| WO2009136965A1 (en) * | 2008-05-06 | 2009-11-12 | Sequella, Inc. | Compositions and methods comprising capuramycin analogues |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3132882A1 (de) * | 1981-08-20 | 1983-03-03 | Cassella Ag, 6000 Frankfurt | Neue piperazinone, ihre herstellung und verwendung |
| FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| WO1994003483A1 (en) * | 1992-07-30 | 1994-02-17 | Chiron Corporation | Endothelin receptor-binding compounds |
| GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
| WO1994026735A1 (en) * | 1993-05-06 | 1994-11-24 | Merrell Dow Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them |
-
1996
- 1996-02-06 WO PCT/US1996/001437 patent/WO1996028441A1/en not_active Application Discontinuation
- 1996-02-06 DE DE69615670T patent/DE69615670T2/de not_active Expired - Lifetime
- 1996-02-06 KR KR1019970706440A patent/KR19980703032A/ko not_active Application Discontinuation
- 1996-02-06 CA CA002215333A patent/CA2215333C/en not_active Expired - Fee Related
- 1996-02-06 AU AU49306/96A patent/AU697599B2/en not_active Ceased
- 1996-02-06 NZ NZ302948A patent/NZ302948A/en unknown
- 1996-02-06 CN CN96192564A patent/CN1067068C/zh not_active Expired - Fee Related
- 1996-02-06 ES ES96905333T patent/ES2164235T3/es not_active Expired - Lifetime
- 1996-02-06 AT AT96905333T patent/ATE206421T1/de not_active IP Right Cessation
- 1996-02-06 JP JP52757896A patent/JP3825472B2/ja not_active Expired - Fee Related
- 1996-02-06 HU HU9702149A patent/HUP9702149A3/hu unknown
- 1996-02-06 DK DK96905333T patent/DK0815105T3/da active
- 1996-02-06 EP EP96905333A patent/EP0815105B1/en not_active Expired - Lifetime
- 1996-02-06 PT PT96905333T patent/PT815105E/pt unknown
- 1996-03-11 ZA ZA961954A patent/ZA961954B/xx unknown
- 1996-03-12 AR ARP960101710A patent/AR002715A1/es active IP Right Grant
- 1996-03-12 IL IL11745396A patent/IL117453A/xx not_active IP Right Cessation
- 1996-03-12 TW TW085102987A patent/TW464647B/zh active
-
1997
- 1997-06-19 US US08/878,695 patent/US5840726A/en not_active Expired - Lifetime
- 1997-09-12 FI FI973671A patent/FI973671A0/fi not_active IP Right Cessation
- 1997-09-12 NO NO19974205A patent/NO314693B1/no unknown
-
1998
- 1998-04-27 US US09/067,386 patent/US5864045A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69615670D1 (de) | 2001-11-08 |
| PT815105E (pt) | 2002-03-28 |
| ATE206421T1 (de) | 2001-10-15 |
| EP0815105A1 (en) | 1998-01-07 |
| CN1178529A (zh) | 1998-04-08 |
| NO974205D0 (no) | 1997-09-12 |
| CA2215333A1 (en) | 1996-09-19 |
| US5840726A (en) | 1998-11-24 |
| IL117453A (en) | 2000-07-26 |
| ES2164235T3 (es) | 2002-02-16 |
| FI973671A (fi) | 1997-09-12 |
| JP3825472B2 (ja) | 2006-09-27 |
| AR002715A1 (es) | 1998-04-29 |
| AU4930696A (en) | 1996-10-02 |
| US5864045A (en) | 1999-01-26 |
| MX9706872A (es) | 1997-11-29 |
| IL117453A0 (en) | 1996-07-23 |
| KR19980703032A (ko) | 1998-09-05 |
| CN1067068C (zh) | 2001-06-13 |
| NO314693B1 (no) | 2003-05-05 |
| DE69615670T2 (de) | 2002-08-08 |
| FI973671A0 (fi) | 1997-09-12 |
| TW464647B (en) | 2001-11-21 |
| AU697599B2 (en) | 1998-10-08 |
| NO974205L (no) | 1997-11-13 |
| HUP9702149A2 (hu) | 1999-06-28 |
| HUP9702149A3 (en) | 1999-07-28 |
| CA2215333C (en) | 2002-01-01 |
| EP0815105B1 (en) | 2001-10-04 |
| JPH11501917A (ja) | 1999-02-16 |
| ZA961954B (en) | 1996-09-17 |
| NZ302948A (en) | 2001-05-25 |
| WO1996028441A1 (en) | 1996-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0804419T3 (da) | Quinolinderivater som tachykinin NK 3-receptor-antagonister | |
| DK0856001T3 (da) | Pyrimidinderivater som 5-HT2C-receptor-antagonister | |
| NO974686D0 (no) | Nye substituerte piperazinderivater med tachykinin reseptor antagonist aktivitet | |
| NZ307625A (en) | 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists | |
| FI973205A (fi) | Indolijohdannaisia 5-HT-reseptoriantagonisteina | |
| NO985225L (no) | Indolderivater nyttige som endotelinreseptorantagonister | |
| NO951613D0 (no) | Ikke-peptidyl tachykinin reseptorantagonister | |
| NO943348D0 (no) | Kondenserte indolderivater som 5HT4-reseptorantagonister | |
| NO974043L (no) | Indolderivater som EAA-antagonister | |
| NO985970L (no) | Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister | |
| FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
| ID24468A (id) | 2-asilaminopropanamina sebagai antagonis reseptor tachykinin | |
| NO992066D0 (no) | Piperazinoderivater som neurokininantagonister | |
| DK0815105T3 (da) | Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister | |
| NO985972L (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| DE69617010D1 (de) | Isazole derivate als fibrinogen-rezeptor-antagonisten | |
| ID24309A (id) | 2-asilaminopropanamina sebagai antagonis reseptor tachykinin | |
| FI941118A0 (fi) | Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina | |
| DK0940391T3 (da) | Quinolinderivater som tachykinin-NK3-receptor-antagonister | |
| FI941117A0 (fi) | Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina | |
| NO963775L (no) | Indol-derivater som CCK-reseptorantagonister |